Week 6 Respiratory and Gout Flashcards

(47 cards)

1
Q

Asthma

A

Chronic inflammatory disorder of the airways
50% results from an immune response to an allergen

Allergen binds to IgE on mast cells
Mast cells release mediators (DRUGS TARGET THESE)
Mediators cause bronchoconstriction and airway inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

COPD

A

3rd leading cause of death
Irreversibel symptoms from:
Chronic bronchitis (chronic cough with excessive sputum production)
Emphysema– enlargement of airspace within the bronchioles/alveoli

Diagnoses: FEV1/FVC= <0.7 (70%)

Inflammation from mediators inhibits protease inhibitors who protect and maintain alveoli integrity; without them enzymes break down elastin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Anti Inflammatory
Glucocorticoids

A

Budesonide and Fluticasone
MOA: < release of inflammatory mediators (histamine, leukotrienes, and prostaglandins)

USE: Asthma prophylaxis and COPD exacerbation mangement

ADE: inhaled: oral thrush; long term adrenal suppression and bone loss

ORAL glucocorticoids can cause toxicity and should not be first line

PT ED: intended for prevention not acute attacks; rinse mouth post use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Anti Inflammatory
Leukotriene Receptor Antagonists

A

Zilueton; Zafirlukast (prototype)
Montelukast (TESTED ON) Only one approved for children 1-3

MOA: high affinity for leukotriene receptors in the airway on pro-inflammatory cells blocking receptor activation

Use: prophylactic and maintenance therapy for asthma; prevention of EIB exercise inducted bronchospasm

ADE: possible neuropsychiatric impact (mood/ suicide)

PT ED: Cannot be used for quick relief from an attack

Provider considerations: SABA preferred for EIB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Anti Inflammatory
Other Category (1 drug)

A

Cromolyn

Inhaled agent that suppresses bronchial inflammation
Use: Prophylaxis in mild to moderate asthma

Less effective than glucocorticoids; not preferred
Only prescribe is pt has an issue with glucocorticoids
SAFEST DRUG
Admin via nebulizer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Anti Inflammatory Life Stages

A

inhaled glucocorticoids are preferred tx for children, pregnant women, breastfeeding, and inhaled is safer than systemic in all categories for older adults

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

MABS Monoclonal Antibodies

A

OmalizuMAB
Tx asthma
MOA: forms complex with IgE reducing amount of IgE available to bind with mast cells limiting mediator release

Approved for ages 6 and ^ for allergy related asthma not controlled by glucocorticoids

Sub Q injection; half life 26 days

Once stopped, will take IgE 1 year to return to pretreatment levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Phosphodieterase 4 Inhibitor

A

Roflumilast

MOA: target ^ cAMP to inhibit inflammation

Use: mange COPD w/ primary chronic bronchitis component; exacerbation prophylaxis

ADE: headache, insomnia, GI (N/V/D weight loss, reduced appetite)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Bronchodilators
Anticholinergic Drugs

A

IpraTROPIUM/ TioTROPIUM

IpraTROPIUM
SAMA
MOA: Blocks muscarinic receptors in bronchi reducing bronchoconstriction

USE: COPD approved

ADE: minimal dry mouth or irritation of pharynx

***PT ED: Risk for ^ interocular pressure; frequent eye exams with glaucoma

TioTROPIUM
Long acting muscarinic antagonist (LAMA)
Same use/ effects peak 3 hours; last 24 hours
Each dose more relief; plateau at 8 days
ADE: dry mouth; less common anticholinergic effects: can’t see, can’t pee; can’t spit, can’t shit)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Bronchodilators
Beta 2 Agonists SABA

A

Albuterol/ Xopenex/ Levalbuterol/ Proair/ Proventil

Use: 1st line acute asthma attacks; prophylaxis EIB
MOA: activates B2 receptors; smooth muscle in lung promotes bronchodilation

Dose: 1-2 breaths
Pt ED: cannot be used for prolonged prophylaxis, only for acute attack and EIB prophylaxis
PRN

Albuterol in Neonates: prevent BPD, relive brochospasm, TTN, viral bronchiolitis (all little research)
Intra-tracheal albuterol and surfactant; positive effect in reducing Intubation- Surfactant Extubations failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Bronchodilators
Beta 2 Agonists LABA

A

Salmeterol/ Formoterol/ Arformoteral

MOA: activates B2 in lung
Use: longterm prophylaxis in pts with frequent asthma attacks; Preferred in COPD

PT ED: Take on a fixed schedule

BLACK BOX: Asthma related deaths from monotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Bronchodilator
Unknown Mechanism

A

Methylxanthine

MOA: unknown
USE: maintenance therapy for asthma; nocturnal asthmatics; not for COPD

ADE: r/t toxicity; NV and tachy-dysrythmias
If toxic dose, stop dosage and consider charcoal

PT ED: Drug interactions: caffeine, tobacco, phenobarb, phenytoin, rifampin, and fluoroquinolone abx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Bronchodilator Life Stage

A

SABAs are for children >2
Methylxanthines for any age (neonates)
Preg: beta 2 agonists exceed risk of uterine relaxation and poor oxygen delivery to fetus
Anticholinergics are the safest
Breastfeeding: avoid methyxanthine
Older: systemic anticholinergics BEERS list
Methyxanthine risk of toxicity; avoid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Treatment Goals ASTHMA

A

Reduce impairment
Reduce Risk

Severity of illness:
Intermittent: Step 1
Mild persistent: Step 2
Moderate persistent: Step 3
Sever persistent: Step 4/5

Step 1: PRN SABA
Step 2: daily low dose ICS and PRN SABA/// OR/// PRN concomitant ICS and SABA
Step 3: Daily and PRN combo of low-dose ICS–Formoterol
Step 4: Daily and PRN combo medium dose–Formoterol
Step 5: Daily medium high dose ICS-LABA + LAMA and PRN SABA
Step 6: Daily high dose ICS-LABA +oral systemic corticosteroids and PRN SABA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Treatment Goals for COPD

A

Reduce Symptoms
Reduce Risk
Diagnosis: GOLD assessment

0-1 Moderate exacerbations not leading to hospitalization:
Group A: bronchodilator
Group B: long acting bronchodilator (LABA or LAMA)

> 2 moderate exacerbations or >1 leading to hospitalization:
Group C: LAMA
Group D: LAMA or LAMA + LABA or ICS + LABA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Allergic Rhinitis

A

Inflammatory disorder affecting upper airway
Sneezing, rhinorrhea, pruitis, nasal congestion
Main cause: Dilation and increased permeability of nasal blood vessels
Triggered: airborne allergens that bind to mask cells
Seasonal: hay fever, occurs in spring and fall, fungus, pollen, weed grass, trees
Perennial: Indoor allergens, pet dander, dust mites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Allergic Rhinitis
Drug Categories and Drugs

A

Inranasal Glucocorticoid: Beclomethasone
Antihistamine: Azelastine/Loratadine
Intranasal Sympathomimetics: Phenylephrine; oxymetazoline
Oral Sympathomimetics: Psuedoephendrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Allergic Rhinitis
Glucocorticoids

A

Beclomethasone/ budesonide/ fluticasone propionate/ triamcinolone
prevent inflammatory response to allergies; reduce symptoms
ADE: nasal irritation, burning/ itching, sore throat, nose bleeds, headache
MOST EFFECTIVE
Metered dose spray
Admin daily

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Allergic Rhinitis
Antihistamines

A

Azelastine/ Olopatadine

H1 receptor antagonist
first line for mild to moderate rhinitis
more effective taken prophylactically
Relieves sneezing and nasal itching but not congestion
ADE: sedation, dry nose, dry mouth, constipation, urinary hesitancy

20
Q

Sympathomimetics (Decongestants)

A

Psuedoephendrine
Activate A1 adrenergic receptors on nasal blood vessels
Only relieves congestion
ADE: Rebound congestion, CNS stimulation, CV impact, abuse

21
Q

TX Allergic Rhinitis based on chief complain

A

Nasal Decongestion: glucocorticoids and oral decongestant

Intermittent sneezing and rhinorrhea: oral and internasal antihistamine

Mild symptoms: oral antihistamine

Moderate to severe: nasal glucocorticoids. intranasal antihistamines, and combo therapy

22
Q

Cough

A

Not all cough is useful
irritation of bronchial mucosa reflex

Opiod antitussive, non opioid antitussive, expectorants, mucolytics

23
Q

Cough opioid antissive

A

Codeine, hydrocodeine

Suppress cough
1/10 of the dose for pain (10-20mg PO)
Not recommended in kids

24
Q

Cough Non opioid antissive

A

Dextromethorphan
Acts in CNS
Can cause euphoria
10-30mg Q 4-8 hours

Diphenhydramine
Antihistamine
mechanism to suppress cough is unclear
Can cause Sedation

Benzonatate Decreases cough by decreasing sensitivity of respiratory tract stretch receptors
Avoid in children < 10
adopt dose 100mg TID

25
Cough Expectorants and Mucolytics
Expectorants Efficacy?? Guanifenesin makes cough more productive Mycolytics Acts directly with mucus to make more watery Acetycysteine and hypertonic saline
26
Cold Combo Remedies
Nasal Decongestant Antitussive Analgesic Antihistamine (suppress mucus secretion) Caffeine (offset sedation from antihistamine) Do not use in children; especially antihistamines and codeine >1 yr: honey for sore throat >2 yr: mentholated chest rubs (VICKS) for cough Acetaminophen and ibuprofen for discomfort
27
Rheumatoid Arthritis
Autoimmune inflammatory disease Attacks joints (hands, wrists, knees) lining of joined becomes inflamed causing damage to tissue can attack HRT/Lungs/Eyes Diagnose: pain/stiffness/tenderness in more than one joint, on both sides
28
Management of Rheumatoid Arthritis
Goal: Relieve symptoms, mange pain, maintain function of joints, delay disease progression DMARDS: Disease Modifying Antirheumatic Drugs conventional, biological, targeted take time to work (weeks-months) Nonsteroidal Anti-inflammatories: manage pain while waiting for DMARDS Glucocorticoids directly injected into joint for flare ups and relief while waiting on DEMARDS
29
DMARDS: Conventional: First line drug
Methotrexate Faster acting than other DMARDS (3-6 weeks to therapeutic range) MOA: Folate antagonist (inhibit DNA) Immunosuppression 2/2: reducing activity of the B and T lymphocytes ADE: BLACK BOX: fatal toxicities to bone marrow, liver, lungs, kidneys, hemorrhagic enteritis, gastrointestinal perforation Can cause fetal death and congenital abnormalities Supplement with folic acid 5mg/week: reduce GI/hepatoxicity Avoid drugs: with liver injury, alcohol, myelosupression Reduces response to vaccines live vaccines are contraindicated Prior to stating: vaccine PNA, Flu, HepB, HPV, Herpes zoster
30
DMARDS: Conventional: 2nd Line
Leflunomide 2nd line therapy Equally as efficacious More expensive and hazardous!!!! Prodrug MOA: Inhibits Tcell proliferation and antibody production ADE: diarrhea; respiratory infection, reversible alopecia and rash Pancytopenia, SJS, peripheral neuropahty; intestinal disease and severe hypertension Hepatotoxic and Immunosupresive Teratogenic: 3 steps to clear system for pregnancy: D/C drug/ Cholestyramine dosed for ll days/ plasma drug levels <20mcg/L (may stay in body up to 2 years if drug is not given) NSAIDS: risk of inhibiting metabolism and ^ drug level in body Rifampin: ^ Leflunomide levels in body do not admin together
31
DMARDS Conventional Sulfa
Sulfasalazine can slow profession of joint deterioration GI reactions; skin reactions; liver injury; none marrow suppression Avoid in Sulfa allergy
32
DMARDS Conventional Hydro
Hydroxychloroquine used only on combo with Methotrexate MOA in RA unknown Delayed onset 3-6 months ADE: retinal damage (directly related to dose levels), caridomyopathy, QTc prolongation, Hypoglycemia
33
DMARDS Biologics TNF Inhibitors
Etanercept Inflixmab Adalimumab Golimumab Certolizumab Pegol Etanercept: first available; inhibit tumor necrosis factor to prevent inflammation Mod-Sever RA Superior to methotrexate ADE: RISK FOR INFECTION/SEPSIS/DEATH injection site reactions children-lymphoma May ^ HRT failure; ^risk of cancer, ^ risk of liver injury Reduce vaccine efficacy Infliximab Admin IV similar to Etanercept
34
DMARDS Biologics B-lymphocyte Depleting Agents
Rituximab Reduce # of B Lymphocytes which cause attach on joints CD20 monoclonal antibody Mod-severe RA in combination with methotrexate in patients who have not responded to TNF inhibitors Admin IV ADE: infusion reaction 80%; premeditate: antihistamine, acetaminophen, methylprednisone Mucocutaneous reactions: SJS, TEN, lichenoid dermatitis (1-3 weeks after) Hep B reactivation Progressive multifocal leukoencephalopathy (severe infection of CNS; d/c if seen immediately)
35
DMARDS Biologics T cell Activation Inhibitors
Abatacept T cells inhabit the synovium of joints in pts with RA; cause autoimmune attach MOA: bings to antigens presenting T cells Mod-Severe RA < symptoms in mod-severe polyarticular juvenile idiopathic arthritis ADE: Headache, upper respiratory infection; nausea IMMUNOSUPRESSION Blunts vaccine effectiveness NOT WITH TNF inhibitors (^risk infection) But yes with conventional DMARDS
36
DMARDS Biologics Interleukin 6 receptor antagonist
Tocilizumab Expensive Only used when not responding to other DMARDS Only combine with methotrexate; all others ^risk of infection ADE: infection; neutropenia; thrombocytopenia; GI perf; liver
37
DMARDS Biologics Interleukin 1 receptor antagonists
Anakinra Mod-severe RA and not responding to other drugs ADE: Severe infection
38
Targeted DMARDS Janus Kinase Inhibitors
Tofacitinib Baricitinib Prevents activation of STAT pathway Failed other DMARD treatment ADE: long term unknown; risk for serious infection
39
RA Recommendations
1st DEMARD moderate disease: Methotrexate Glucocorticoids: if conventional DMARD prescribed with a therapeutic dose in 3-6 weeks recommended not to use; however, >3 months wait then use Low disease RA: Hydroxchloroquine over csDMARDs
40
Admin of methotrexate
initially oral is recommended over sub q Titrate to a dose of 15mg within 4-6 weeks Not tolerating weekly dosing; try split dose of oral or sub q weekly and increase folic acid before switching to an alternative DMARD
41
RA Lifespan DMARD
children taking TNF risk for lymphoma Pregnant: TNF cat B, Hydroxychloroquine and sulfasalazine cat B Azathioprine is teratogenic Leflunomide: 3 step process to clear system before trying to get pregnant; toxic to fetus Methotrexate toxic to fetus Do not take DMARDS while breastfeeding Older: > risk for infection
42
Gout
recurring inflammatory disorder that can be painful and disabling Sever joint pain; hyperuricemia (>6 crystal formation) Risk: Male, onset, alcohol, red meat, CHF, HTN, DM, Metabolic syndrome, kidney dysfunction Diagnose: blood uric levels, uric acid crystals in affected joints only diagnosed during a flair up First sign: big toe in 50% of cases
43
Acute Attack Gout
Colchicine Anti inflammatory gout attack: ^ dose, relief in hours Prevention low dose Administer with ULT to prophylactically prevent flare ups which waiting for ULT to be effective ADE: N/V/D Myelosuppression (leukopenia) Myopathy Interacts with STATINS/ PGP inhibitors or CYP3A4 inhibitors
44
Long Term Gout Reduce urate goal: uric acid level 6 or lower to dissolve or prevent crystals
Allopurinol MOA: Xanthine oxidase inhibitor ADE: N/V/D; cataract formation; bone marrow suppression; rash Drug drug: theophylline and WARFARIN Probenecid MOA: acts at renal tubules to inhibit reabsorption of uric acid Delay therapy if onset of acute attack: will take wks/months for drug ADE: N/V/D, rash, hypersensitivity, G6PD deficiency Renal injury: weeks to months to lower uric acid; crystals can form initially; reduce the risk by drinking 3 liters of water daily to alkalinize urine Pegloticase IV Admin last line for those nor responding to oral very expensive ADE: anaphylaxis in 6% pt 40% infusion reactions provide antihistamine and glucocorticoid prior to admin
45
Gout Management
Urate lowing therapy not recommended in patients experiencing first attack ULT for subcutaneous tophi, radiographic damage; frequent flare ups (>2 annually) Not recommended in pts with asymptomatic hyperuricemia
46
Gout ULT First line
Allopurinol > Probenecid> Pegloticase Admin NSAIDS, colchicine, steroids for anti-inflammatory prophylaxis when starting a UTL and continue for 3-6 months
47
Random MABS
Bezlotoxumab: C Diff; combine with abx for bacterial tx Erenmab: migraine; monthly sub q injection ADE: immune reaction, anaphylaxis, cytokine release syndrome (manage with tocilizumb), derm/GI/liver toxicity